Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127990) titled 'A comparative clinical study on the effect of dapagliflozin combined with CGM versus SMBG on glycemic control in patients with type 2 diabetes mellitus based on the DP-DCT platform' on July 12.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Third Xiangya Hospital of Central South University
Condition:
Type 2 diabetes
Intervention:
Group A:Initiate dapagliflozin therapy in combination with open-label continuous glucose monitoring for glucose monitoring
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Group A:60;Group ...